Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Continuous Glucose Monitoring Device Market, by Application
1.4.2 Global Continuous Glucose Monitoring Device Market, by End User
1.4.3 Global Continuous Glucose Monitoring Device Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Continuous Glucose Monitoring Device Market by Component
3.1 Global Sensors Market by Region
3.2 Global Transmitters Market by Region
3.3 Global Receivers Market by Region
Chapter 4. Global Continuous Glucose Monitoring Device Market by End-user
4.1 Global Hospitals Continuous Glucose Monitoring Device Market by Region
4.2 Global Homecare Settings Market by Region
4.3 Global Other End Users Market by Region
Chapter 5. Global Continuous Glucose Monitoring Device Market by Region
5.1 North America Continuous Glucose Monitoring Device Market
5.1.1 North America Continuous Glucose Monitoring Device Market by Component
5.1.1.1 North America Sensors Market by Country
5.1.1.2 North America Transmitters Market by Country
5.1.1.3 North America Receivers Market by Country
5.1.2 North America Continuous Glucose Monitoring Device Market by End-user
5.1.2.1 North America Hospitals Continuous Glucose Monitoring Device Market by Country
5.1.2.2 North America Homecare Settings Market by Country
5.1.2.3 North America Other End Users Market by Country
5.1.3 North America Continuous Glucose Monitoring Device Market by Country
5.1.3.1 US Continuous Glucose Monitoring Device Market
5.1.3.1.1 US Continuous Glucose Monitoring Device Market by Component
5.1.3.1.2 US Continuous Glucose Monitoring Device Market by End-user
5.1.3.2 Canada Continuous Glucose Monitoring Device Market
5.1.3.2.1 Canada Continuous Glucose Monitoring Device Market by Component
5.1.3.2.2 Canada Continuous Glucose Monitoring Device Market by End-user
5.1.3.3 Mexico Continuous Glucose Monitoring Device Market
5.1.3.3.1 Mexico Continuous Glucose Monitoring Device Market by Component
5.1.3.3.2 Mexico Continuous Glucose Monitoring Device Market by End-user
5.1.3.4 Rest of North America Continuous Glucose Monitoring Device Market
5.1.3.4.1 Rest of North America Continuous Glucose Monitoring Device Market by Component
5.1.3.4.2 Rest of North America Continuous Glucose Monitoring Device Market by End-user
5.2 Europe Continuous Glucose Monitoring Device Market
5.2.1 Europe Continuous Glucose Monitoring Device Market by Component
5.2.1.1 Europe Sensors Market by Country
5.2.1.2 Europe Transmitters Market by Country
5.2.1.3 Europe Receivers Market by Country
5.2.2 Europe Continuous Glucose Monitoring Device Market by End-user
5.2.2.1 Europe Hospitals Continuous Glucose Monitoring Device Market by Country
5.2.2.2 Europe Homecare Settings Market by Country
5.2.2.3 Europe Other End Users Market by Country
Chapter 6. Europe Continuous Glucose Monitoring Device Market by Country
6.1.1.1 Germany Continuous Glucose Monitoring Device Market
6.1.1.1.1 Germany Continuous Glucose Monitoring Device Market by Component
6.1.1.1.2 Germany Continuous Glucose Monitoring Device Market by End-user
6.1.1.2 UK Continuous Glucose Monitoring Device Market
6.1.1.2.1 UK Continuous Glucose Monitoring Device Market by Component
6.1.1.2.2 UK Continuous Glucose Monitoring Device Market by End-user
6.1.1.3 France Continuous Glucose Monitoring Device Market
6.1.1.3.1 France Continuous Glucose Monitoring Device Market by Component
6.1.1.3.2 France Continuous Glucose Monitoring Device Market by End-user
6.1.1.4 Russia Continuous Glucose Monitoring Device Market
6.1.1.4.1 Russia Continuous Glucose Monitoring Device Market by Component
6.1.1.4.2 Russia Continuous Glucose Monitoring Device Market by End-user
6.1.1.5 Spain Continuous Glucose Monitoring Device Market
6.1.1.5.1 Spain Continuous Glucose Monitoring Device Market by Component
6.1.1.5.2 Spain Continuous Glucose Monitoring Device Market by End-user
6.1.1.6 Italy Continuous Glucose Monitoring Device Market
6.1.1.6.1 Italy Continuous Glucose Monitoring Device Market by Component
6.1.1.6.2 Italy Continuous Glucose Monitoring Device Market by End-user
6.1.1.7 Rest of Europe Continuous Glucose Monitoring Device Market
6.1.1.7.1 Rest of Europe Continuous Glucose Monitoring Device Market by Component
6.1.1.7.2 Rest of Europe Continuous Glucose Monitoring Device Market by End-user
6.2 Asia Pacific Continuous Glucose Monitoring Device Market
6.2.1 Asia Pacific Continuous Glucose Monitoring Device Market by Component
6.2.1.1 Asia Pacific Sensors Market by Country
6.2.1.2 Asia Pacific Transmitters Market by Country
6.2.1.3 Asia Pacific Receivers Market by Country
6.2.2 Asia Pacific Continuous Glucose Monitoring Device Market by End-user
6.2.2.1 Asia Pacific Hospitals Continuous Glucose Monitoring Device Market by Country
6.2.2.2 Asia Pacific Homecare Settings Market by Country
6.2.2.3 Asia Pacific Other End Users Market by Country
6.2.3 Asia Pacific Continuous Glucose Monitoring Device Market by Country
6.2.3.1 China Continuous Glucose Monitoring Device Market
6.2.3.1.1 China Continuous Glucose Monitoring Device Market by Component
6.2.3.1.2 China Continuous Glucose Monitoring Device Market by End-user
6.2.3.2 Japan Continuous Glucose Monitoring Device Market
6.2.3.2.1 Japan Continuous Glucose Monitoring Device Market by Component
6.2.3.2.2 Japan Continuous Glucose Monitoring Device Market by End-user
6.2.3.3 India Continuous Glucose Monitoring Device Market
6.2.3.3.1 India Continuous Glucose Monitoring Device Market by Component
6.2.3.3.2 India Continuous Glucose Monitoring Device Market by End-user
6.2.3.4 South Korea Continuous Glucose Monitoring Device Market
6.2.3.4.1 South Korea Continuous Glucose Monitoring Device Market by Component
6.2.3.4.2 South Korea Continuous Glucose Monitoring Device Market by End-user
6.2.3.5 Singapore Continuous Glucose Monitoring Device Market
6.2.3.5.1 Singapore Continuous Glucose Monitoring Device Market by Component
6.2.3.5.2 Singapore Continuous Glucose Monitoring Device Market by End-user
6.2.3.6 Malaysia Continuous Glucose Monitoring Device Market
6.2.3.6.1 Malaysia Continuous Glucose Monitoring Device Market by Component
6.2.3.6.2 Malaysia Continuous Glucose Monitoring Device Market by End-user
6.2.3.7 Rest of Asia Pacific Continuous Glucose Monitoring Device Market
6.2.3.7.1 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by Component
6.2.3.7.2 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by End-user
6.3 LAMEA Continuous Glucose Monitoring Device Market
6.3.1 LAMEA Continuous Glucose Monitoring Device Market by Component
6.3.1.1 LAMEA Sensors Market by Country
6.3.1.2 LAMEA Transmitters Market by Country
6.3.1.3 LAMEA Receivers Market by Country
6.3.2 LAMEA Continuous Glucose Monitoring Device Market by End-user
6.3.2.1 LAMEA Hospitals Continuous Glucose Monitoring Device Market by Country
6.3.2.2 LAMEA Homecare Settings Market by Country
6.3.2.3 LAMEA Other End Users Market by Country
6.3.3 LAMEA Continuous Glucose Monitoring Device Market by Country
6.3.3.1 Brazil Continuous Glucose Monitoring Device Market
6.3.3.1.1 Brazil Continuous Glucose Monitoring Device Market by Component
6.3.3.1.2 Brazil Continuous Glucose Monitoring Device Market by End-user
6.3.3.2 Argentina Continuous Glucose Monitoring Device Market
6.3.3.2.1 Argentina Continuous Glucose Monitoring Device Market by Component
6.3.3.2.2 Argentina Continuous Glucose Monitoring Device Market by End-user
6.3.3.3 UAE Continuous Glucose Monitoring Device Market
6.3.3.3.1 UAE Continuous Glucose Monitoring Device Market by Component
6.3.3.3.2 UAE Continuous Glucose Monitoring Device Market by End-user
6.3.3.4 Saudi Arabia Continuous Glucose Monitoring Device Market
6.3.3.4.1 Saudi Arabia Continuous Glucose Monitoring Device Market by Component
6.3.3.4.2 Saudi Arabia Continuous Glucose Monitoring Device Market by End-user
6.3.3.5 South Africa Continuous Glucose Monitoring Device Market
6.3.3.5.1 South Africa Continuous Glucose Monitoring Device Market by Component
6.3.3.5.2 South Africa Continuous Glucose Monitoring Device Market by End-user
6.3.3.6 Nigeria Continuous Glucose Monitoring Device Market
6.3.3.6.1 Nigeria Continuous Glucose Monitoring Device Market by Component
6.3.3.6.2 Nigeria Continuous Glucose Monitoring Device Market by End-user
6.3.3.7 Rest of LAMEA Continuous Glucose Monitoring Device Market
6.3.3.7.1 Rest of LAMEA Continuous Glucose Monitoring Device Market by Component
6.3.3.7.2 Rest of LAMEA Continuous Glucose Monitoring Device Market by End-user
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.2.5.3 Approvals:
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 Novo Nordisk A/S
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.5 DexCom, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Approvals:
7.6 Ypsomed AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Senseonics Holdings, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.8 GlySens, Incorporated
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.1 Echo Therapeutics, Inc.
7.10.1 Company Overview
7.11 Johnson and Johnson
7.11.1 Company Overview
7.11.2 Financial Analysis
7.11.3 Segmental &Regional Analysis
7.11.4 Research & Development Expenses
7.11.5 Recent strategies and developments:
7.11.5.1 Approvals:
Unique Offerings 
